Address: 18201 Von Karman Ave, Suite 470. Irvine, CA 92612
Tel: (949) 769-6543
Web: http://www.taimedbiologics.com/
TaiMed Biologics was formed on September 4, 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy the unmet medical needs of patients around the world.
The company signed an agreement with Genentech for the licensing of Ibalizumab shortly after its formation. This drug candidate, also known as TMB-355, is a proprietary humanized anti-CD4 monoclonal antibody for the treatment of HIV/AIDS. A phase-2b clinical trial is currently underway and the coma expect the trial to be completed in Q1 2011.
Stéphane Péden, general manager of the Chamber of Commerce & Industry France Taiwan (CCIFT), describes how the Chamber facilitates business relations between France and Taiwan, the challenges faced by French…
Joyce Lee, general manager of Amgen Taiwan, shares her journey of building up the affiliate after only having entered the market three years ago and goes on to offer insights…
Dr. Wen-cherng Tsai, founder and chairman of SuperLab, explains the company’s unique business model as the only third-party fair testing organization and pre-clinical CRO across the medical, chemical and biological…
Michelle Lin, CEO, and Hsu Chang, Senior Advisor of EpiSonica, highlight the innovative new solutions that the company has created for women’s health and medical imagining. The advanced technology will…
Dr Dean Tsao, chairman and CEO of PlexBio Co., Ltd., shares the story of his impressive expert background which led him to form the in vitro diagnostics (IVD) company in…
Dr Hardy Chan shares the story of how he came out of retirement to lead Allianz Pharmascience; an up-and-coming biotech which aims to meet the unmet medical needs of rare…
Grace Yang, general manager of TSH Biopharm, discusses how the company is uniquely positioned to deliver end-to-end healthcare solutions to the APAC region in the areas of cardiovascular, gastrointestinal, autoimmune,…
Dr Jeffery Tzen, president of the Taiwanese Society of Molecular Medicine and precision medicine key opinion leader, offers insights into Taiwan’s adoption of the emerging field. In order to…
Eric Yang, secretary general of the Taiwan Precision Medical and Molecular Diagnostics Industry Association (PMMD), speaks about the key challenges facing the sector and the top priorities of the organization…
Taiwan has long been a leader in biotechnology research and development. With the government’s emphasis on higher education and research, Taiwan has trained a diverse pool of talent in the…
Dr Mien-Chie Hung, president of China Medical University, shares his personal mission upon taking the role only three months ago. Dr Hung also elaborates on the research strengths of CMU…
Pei-Li Li, CSO and executive VP of VtR Inc, expands on the company’s unique positioning and expertise as one of the few local teams in the greater China area that…
See our Cookie Privacy Policy Here
